Atlas Trials

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Clinical trial NCT04303780 · COMPLETED

Trial details

NCT number
NCT04303780
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
Start date
2020-06-04
Primary completion
2022-08-02
Enrollment
345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.